Answering today’s big questions in progressive MS
Language
Description
In this webcast from The International Progressive MS Alliance a panel of experts discuss insights into understanding what causes progression, finding ways to shorten the time it takes to conduct clinical trials and identifying potential treatment breakthroughs.
COVID-19 is a big concern for people with MS. Early efforts are underway to understand the impact the virus is having on people with MS and what strategies can help minimise its effect. Discover what is being learned through studies at a global level, in Italy, North America and elsewhere.
Jon Strum facilitates the panel discussion. Jon is joined by Professor Alan Thompson, Chair of the Progressive MS Alliance Scientific Steering Committee and Pro Vice-Provost and Dean of the Faculty of Brain Sciences at University College London; Professor Maria Pia Sormani, University of Genoa, biostatistics expert in MS and lead in a COVID-19 and MS study; and Timothy Coetzee, PhD, Chief Advocacy, Service and Research Officer at the National MS Society (U.S.) and member of the Alliance Scientific Steering Committee.
Published: 2020
Contact us
If you have any questions or feedback on our resource, please contact us on our website.
Contact usHelp us add subtitles to this video
We're always looking for member organisations to add translated subtitles to video resources, so they can be accessible to people in different countries around the world. Not a member? If we don't have a member that speaks your language and you would like to add subtitles to this resource, we'd love to hear from you to discuss options and explore what's possible!
Contact usAccelerating Breakthough Treatments in Progressive MS
Discovering Life-Changing Treatments for People with Progressive MS
Answers to your Questions: Progressive MS Treatment and Research
Preview
